Approval of gene therapies for two blood cancers led to an ‘explosion of interest’ in 2017

CAR-T cell therapy treats patients for whom other therapies haven’t worked

CAR-T cells

CANCER CRUSH  In CAR-T cell therapy, a cancer treatment approved by the FDA this year for certain blood cancers, a patient’s T cells (teal) are genetically modified to hunt down and kill cancer cells (blue).

Prasad Adusumilli, ©2017 Memorial Sloan Kettering Cancer Center

This article is only available to Science News subscribers.

Subscribers, enter your e-mail address to access our archives.

Not a subscriber?

Science News is a nonprofit.

Support us by subscribing now.

More Stories from Science News on Health & Medicine

From the Nature Index

Paid Content